Delirium. Delirium due to known physiological condition
Conditions
Interventions
Intervention 1: Intervention group 1: Patients in this group will receive 3 mg of melatonin at night for 5 days. Intervention 2: Intervention group 2: The patients in this group will receive haloperid
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: All patients for whom a diagnosis of delirium was made by DSM-criteria were included. Age 18 to 80 years RASS criterion greater than or equal to 3 Absence of primary neurological disease such as stroke, dementia, psychosis Failure to enter patients who are in a coma for more than 24 hours and have a structural reason for their low level of consciousness No history of seizures Absence of underlying disease The patient should not be so restless that there is a possibility of harming herself or others and she cannot wait for the response of oral medication. Absence of pregnancy and breastfeeding Insensitivity to drugs Absence of QTc greater than 440 ms No history of SSRI use
Exclusion criteria
Exclusion criteria: Lack of consent of the companions (the person in charge of the patient) to receive the medicine and the patient's participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation. Timepoint: Daily to 7 days. Method of measurement: Based on the RASS score.;Illness severity. Timepoint: Daily to 7 days. Method of measurement: Apachi score.;Number of hospitalization days. Timepoint: End of study. Method of measurement: File.;Mortality. Timepoint: End of study. Method of measurement: File. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hesamedin Modir
Arak University of Medical Sciences
Outcome results
None listed